- Home
- ORIC vs FFA Comparison
ORIC vs FFA Comparison
Compare ORIC & FFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- FFA
- Stock Information
- Founded
- ORIC 2014
- FFA 2004
- Country
- ORIC United States
- FFA United States
- Employees
- ORIC N/A
- FFA N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- FFA Investment Managers
- Sector
- ORIC Health Care
- FFA Finance
- Exchange
- ORIC Nasdaq
- FFA Nasdaq
- Market Cap
- ORIC 362.9M
- FFA 400.0M
- IPO Year
- ORIC 2020
- FFA N/A
- Fundamental
- Price
- ORIC $5.08
- FFA $19.13
- Analyst Decision
- ORIC Strong Buy
- FFA
- Analyst Count
- ORIC 8
- FFA 0
- Target Price
- ORIC $18.83
- FFA N/A
- AVG Volume (30 Days)
- ORIC 630.2K
- FFA 26.1K
- Earning Date
- ORIC 05-05-2025
- FFA 01-01-0001
- Dividend Yield
- ORIC N/A
- FFA 6.72%
- EPS Growth
- ORIC N/A
- FFA N/A
- EPS
- ORIC N/A
- FFA N/A
- Revenue
- ORIC N/A
- FFA N/A
- Revenue This Year
- ORIC N/A
- FFA N/A
- Revenue Next Year
- ORIC N/A
- FFA N/A
- P/E Ratio
- ORIC N/A
- FFA N/A
- Revenue Growth
- ORIC N/A
- FFA N/A
- 52 Week Low
- ORIC $3.90
- FFA $15.84
- 52 Week High
- ORIC $14.67
- FFA $19.30
- Technical
- Relative Strength Index (RSI)
- ORIC 44.71
- FFA 55.83
- Support Level
- ORIC $4.52
- FFA $18.93
- Resistance Level
- ORIC $5.83
- FFA $19.40
- Average True Range (ATR)
- ORIC 0.52
- FFA 0.27
- MACD
- ORIC 0.07
- FFA 0.13
- Stochastic Oscillator
- ORIC 40.58
- FFA 83.89
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About FFA First Trust Enhanced Equity Income Fund
First Trust Enhanced Equity Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide a high level of current income and gains and, to a lesser extent, capital appreciation. The Fund pursues its investment objective by investing in a diversified portfolio of equity securities.